BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23830977)

  • 1. Efficient heterologous antigen gene delivery and expression by a replication-attenuated BoHV-4-based vaccine vector.
    Capocefalo A; Mangia C; Franceschi V; Jacca S; van Santen VL; Donofrio G
    Vaccine; 2013 Aug; 31(37):3906-14. PubMed ID: 23830977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine herpesvirus 4 glycoprotein B is indispensable for lytic replication and irreplaceable by VSVg.
    Franceschi V; Capocefalo A; Cavirani S; Donofrio G
    BMC Vet Res; 2013 Jan; 9():6. PubMed ID: 23302472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs.
    Donofrio G; Taddei S; Franceschi V; Capocefalo A; Cavirani S; Martinelli N; Ottonello S; Ferrari M
    Vaccine; 2011 Jan; 29(5):867-72. PubMed ID: 21115049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor.
    Franceschi V; Capocefalo A; Jacca S; Rosamilia A; Cavirani S; Xu F; Qiao W; Donofrio G
    BMC Vet Res; 2015 Aug; 11():224. PubMed ID: 26307352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model.
    Donofrio G; Cavirani S; Vanderplasschen A; Gillet L; Flammini CF
    Clin Vaccine Immunol; 2006 Nov; 13(11):1246-54. PubMed ID: 16928886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
    PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen.
    Franceschi V; Capocefalo A; Calvo-Pinilla E; Redaelli M; Mucignat-Caretta C; Mertens P; Ortego J; Donofrio G
    Vaccine; 2011 Apr; 29(16):3074-82. PubMed ID: 21320537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of bovine herpesvirus 4 based vector in chicken.
    Donofrio G; Manarolla G; Ravanetti L; Sironi G; Cavirani S; Cabassi CS; Flammini CF; Rampin T
    J Virol Methods; 2008 Mar; 148(1-2):303-6. PubMed ID: 18243344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and growth properties of bovine herpesvirus type 5 recombinants defective in the glycoprotein E or thymidine kinase gene or both.
    Brum MC; Weiblen R; Flores EF; Chowdhury SI
    Braz J Med Biol Res; 2010 Feb; 43(2):217-24. PubMed ID: 19893987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a transposon insertion mutant library for bovine herpesvirus 4 cloned as a bacterial artificial chromosome by in vitro MuA based DNA transposition system.
    Donofrio G; Martignani E; Sartori C; Vanderplasschen A; Cavirani S; Flammini CF; Gillet L
    J Virol Methods; 2007 Apr; 141(1):63-70. PubMed ID: 17182112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
    Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
    Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A virus vector based on Canine Herpesvirus for vaccine applications in canids.
    Strive T; Hardy CM; Wright J; Reubel GH
    Vet Microbiol; 2007 Jan; 119(2-4):173-83. PubMed ID: 17079096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD.
    Donofrio G; Sartori C; Franceschi V; Capocefalo A; Cavirani S; Taddei S; Flammini CF
    Vaccine; 2008 Nov; 26(48):6031-42. PubMed ID: 18812200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.
    Donofrio G; Franceschi V; Capocefalo A; Taddei S; Sartori C; Bonomini S; Cavirani S; Cabassi CS; Flammini CF
    Clin Vaccine Immunol; 2009 Nov; 16(11):1675-86. PubMed ID: 19793901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on the in vitro replication and genomic variability of Argentinean field isolates of bovine herpesvirus type 4 (BoHV-4).
    Verna AE; Pérez SE; Manrique JM; Leunda MR; Odeón AC; Jones LR
    Virus Genes; 2016 Jun; 52(3):372-8. PubMed ID: 26995219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine herpesvirus 4 ORF73 is dispensable for virus growth in vitro, but is essential for virus persistence in vivo.
    Thirion M; Machiels B; Farnir F; Donofrio G; Gillet L; Dewals B; Vanderplasschen A
    J Gen Virol; 2010 Oct; 91(Pt 10):2574-84. PubMed ID: 20592111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning.
    Gillet L; Daix V; Donofrio G; Wagner M; Koszinowski UH; China B; Ackermann M; Markine-Goriaynoff N; Vanderplasschen A
    J Gen Virol; 2005 Apr; 86(Pt 4):907-917. PubMed ID: 15784885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bovine herpesvirus 5 recombinant defective in the thymidine kinase (TK) gene and a double mutant lacking TK and the glycoprotein E gene are fully attenuated for rabbits.
    Silva SC; Brum MC; Weiblen R; Flores EF; Chowdhury SI
    Braz J Med Biol Res; 2010 Feb; 43(2):150-9. PubMed ID: 20027480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction, characterization and immunogenicity of a glycoprotein E negative bovine herpesvirus-1.1 Egyptian strain "Abu-Hammad".
    El-Kholy AA; Rady DI; Abdou ER; Elseafy MM; Abdelrahman KA; Soliman H
    J Virol Methods; 2013 Dec; 194(1-2):74-81. PubMed ID: 23962750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting persistent infection for selection of bovine herpesvirus 4 recombinants.
    Donofrio G; Martignani E; Cavirani S; Flammini CF
    J Virol Methods; 2005 Sep; 128(1-2):6-13. PubMed ID: 15885813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.